International Urology and Nephrology

, Volume 44, Issue 5, pp 1549–1557

Kidney transplantation after desensitization in sensitized patients: a Korean National Audit

  • Kyu Ha Huh
  • Beom Seok Kim
  • Jaeseok Yang
  • Jeongmyung Ahn
  • Myung-Gyu Kim
  • Jae Berm Park
  • Jong Man Kim
  • Byung-Ha Chung
  • Joong Kyung Kim
  • Jin Min Kong
Nephrology – Original Paper



The number of end-stage renal disease (ESRD) patients with preformed antibodies waiting for a kidney transplant has been increasing lately. We conducted a nationwide study on the outcomes of kidney transplantation after desensitization in Korea.


Six transplant centers have run desensitization programs. The patients who underwent living donor kidney transplantation after desensitization from 2002 to 2010 were retrospectively analyzed.


A total of 86 cases were enrolled. Thirty-five of these were cases of re-transplantation (40.7 %). Indications of desensitization were positive complement-dependent cytotoxicity (CDC) cross-match responses (CDC+, 36.0 %), positive flow-cytometric cross-match responses (FCX+, 54.7 %), and positive donor-specific antibodies (DSA+, 8.1 %). The desensitization protocols used pre-transplant plasmapheresis (95.3 %), intravenous immunoglobulin (62.8 %), and rituximab (67.4 %). Acute rejection occurred in 18 patients (20.9 %), graft failure occurred in 4 patients, and the 3-year graft survival rate was 93.8 %. The presence of DSA increased the acute rejection rate (P = 0.015) and decreased the 1-year post-transplant estimated glomerular filtration rate (P = 0.006). Although rejection-free survival rates did not differ significantly between the CDC+ and FCX+ groups, the 1-year estimated glomerular filtration rate was lower in the CDC+ group (P = 0.010). Infectious and significant bleeding complications occurred in 15.5 % and 4.7 % of cases, respectively.


Kidney transplantation after desensitization had good graft outcomes and tolerable complications in Korea, and therefore, this therapy can be recommended for sensitized ESRD patients.


Immunologic desensitization Kidney transplantation Rejection 


  1. 1.
    Vo AA, Lukovsky M, Toyoda M, Wang J, Reinsmoen NL, Lai CH et al (2008) Rituximab and intravenous immune globulin for desensitization during renal transplantation. N Engl J Med 359(3):242–251PubMedCrossRefGoogle Scholar
  2. 2.
    Joo SY, Ha J, Kim SJ, Park MH (2009) Analysis of panel reactive antibody in patients awaiting renal transplantation. J Korean Soc Transplant 23(1):28–35Google Scholar
  3. 3.
    Marfo K, Lu A, Ling M, Akalin E (2011) Desensitization protocols and their outcome. Clin J Am Soc Nephrol 6(4):922–936PubMedCrossRefGoogle Scholar
  4. 4.
    Montgomery RA, Zachary AA (2004) Transplanting patients with a positive donor-specific crossmatch: a single center’s perspective. Pediatr Transplant 8(6):535–542PubMedCrossRefGoogle Scholar
  5. 5.
    Stegall MD, Gloor J, Winters JL, Moore SB, Degoey S (2006) A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody. Am J Transplant 6(2):346–351PubMedCrossRefGoogle Scholar
  6. 6.
    Vo AA, Wechsler EA, Wang J, Peng A, Toyoda M, Lukovsky M et al (2008) Analysis of subcutaneous (SQ) alemtuzumab induction therapy in highly sensitized patients desensitized with IVIG and rituximab. Am J Transplant 8(1):144–149PubMedGoogle Scholar
  7. 7.
    Jordan SC, Vo A, Bunnapradist S, Toyoda M, Peng A, Puliyanda D et al (2003) Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients. Transplantation 76(4):631–636PubMedCrossRefGoogle Scholar
  8. 8.
    West-Thielke P, Herren H, Thielke J, Oberholzer J, Sankary H, Raofi V et al (2008) Results of positive cross-match transplantation in African American renal transplant recipients. Am J Transplant 8(2):348–354PubMedCrossRefGoogle Scholar
  9. 9.
    Haririan A, Nogueira J, Kukuruga D, Schweitzer E, Hess J, Gurk-Turner C et al (2009) Positive cross-match living donor kidney transplantation: longer-term outcomes. Am J Transplant 9(3):536–542PubMedCrossRefGoogle Scholar
  10. 10.
    Segev DL, Wang JG, Gloor J, Stegall M, Kapur S, Dunn T et al (2011) Risk of HLA incompatible kidney transplants by antibody strength: Initial results from a national study of 603 patients. Am J Transplant 11(Suppl 2):136Google Scholar
  11. 11.
    US Renal Data System (2011) USRDS 2010 annual data report: Atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney DiseasesGoogle Scholar
  12. 12.
    Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY et al (1999) Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341(23):1725–1730PubMedCrossRefGoogle Scholar
  13. 13.
    Montgomery RA, Lonze BE, King KE, Kraus ES, Kucirka LM, Locke JE et al (2011) Desensitization in HLA-incompatible kidney recipients and survival. N Engl J Med 365(4):318–326PubMedCrossRefGoogle Scholar
  14. 14.
    Segev DL, Gentry SE, Warren DS, Reeb B, Montgomery RA (2005) Kidney paired donation and optimizing the use of live donor organs. JAMA 293(15):1883–1890PubMedCrossRefGoogle Scholar
  15. 15.
    Huh KH, Kim SI, Joo DJ, Ju MK, Chang HK, Kim HJ et al (2009) Efficacy of a negative conversion trial and subsequent living donor kidney transplant outcome in recipients with a positive lymphocyte crossmatch. Nephron Clin Pract 111(1):c49–c54PubMedCrossRefGoogle Scholar
  16. 16.
    Yoon HE, Hyoung BJ, Hwang HS, Lee SY, Jeon YJ, Song JC (2009) Successful renal transplantation with desensitization in highly sensitized patients: a single center experience. J Korean Med Sci 24(Suppl l):S148–S155PubMedCrossRefGoogle Scholar
  17. 17.
    Kim SM, Lee C, Lee JP, Kim EM, Ha J, Kim SJ (2009) Kidney transplantation in sensitized recipients; a single center experience. J Korean Med Sci 24(Supp l):S143–S147PubMedCrossRefGoogle Scholar
  18. 18.
    Garonzik Wang JM, Montgomery RA, Kucirka LM, Berger JC, Warren DS, Segev DL (2011) Incompatible live-donor kidney transplantation in the United States: results of a national survey. Clin J Am Soc Nephrol 6(8):2041–2046PubMedCrossRefGoogle Scholar
  19. 19.
    Racusen LC, Colvin RB, Solez K, Mihatsch MJ, Halloran PF, Campbell PM et al (2003) Antibody-mediated rejection criteria-an addition to the Banff ‘97 classification of renal allograft rejection. Am J Transplant 3(6):14–706CrossRefGoogle Scholar
  20. 20.
    Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 130(6):461–470PubMedGoogle Scholar
  21. 21.
    Gloor JM, Winters JL, Cornell LD, Fix LA, DeGoey SR, Knauer RM et al (2010) Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation. Am J Transplant 10(3):582–589PubMedCrossRefGoogle Scholar
  22. 22.
    Thielke JJ, West-Thielke PM, Herren HL, Bareato U, Ommert T, Vidanovic V et al (2009) Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience. Transplantation 87(2):268–273PubMedCrossRefGoogle Scholar
  23. 23.
    Vo AA, Peng A, Toyoda M, Kahwaji J, Cao K, Lai CH et al (2010) Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation. Transplantation 89(9):1095–1102PubMedCrossRefGoogle Scholar
  24. 24.
    Akalin E, Dinavahi R, Friedlander R, Ames S, de Boccardo G, Sehgal V et al (2008) Addition of plasmapheresis decreases the incidence of acute antibody-mediated rejection in sensitized patients with strong donor-specific antibodies. Clin J Am Soc Nephrol 3(4):1160–1167PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, B.V. 2012

Authors and Affiliations

  • Kyu Ha Huh
    • 1
  • Beom Seok Kim
    • 2
  • Jaeseok Yang
    • 3
    • 4
  • Jeongmyung Ahn
    • 5
  • Myung-Gyu Kim
    • 3
  • Jae Berm Park
    • 6
  • Jong Man Kim
    • 7
  • Byung-Ha Chung
    • 8
  • Joong Kyung Kim
    • 9
  • Jin Min Kong
    • 5
  1. 1.Department of SurgeryYonsei University College of MedicineSeoulRepublic of Korea
  2. 2.Department of Internal MedicineYonsei University College of MedicineSeoulRepublic of Korea
  3. 3.Transplantation CenterSeoul National University HospitalSeoulRepublic of Korea
  4. 4.Transplantation Research InstituteSeoul National University College of MedicineSeoulRepublic of Korea
  5. 5.Department of Internal MedicineMaryknoll Medical CenterBusanKorea
  6. 6.Department of SurgeryUniversity of Ulsan College of MedicineSeoulSouth Korea
  7. 7.Department of SurgerySungkyunkwan University School of MedicineSeoulRepublic of Korea
  8. 8.Department of Internal MedicineThe Catholic University of KoreaSeoulSouth Korea
  9. 9.Department of MedicineBong Seng HospitalBusanKorea

Personalised recommendations